Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07633600
PHASE4

Phenotype Guided Vasoactive Medication During Kidney Transplantation

Sponsor: Jennifer Cutler

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.

Official title: Intraoperative Circulation Phenotyping to Guide Vasoactive Medication in Kidney Transplant Recipients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

255

Start Date

2026-06-01

Completion Date

2027-12-01

Last Updated

2026-06-08

Healthy Volunteers

No

Interventions

DRUG

Phenotype-Guided Vasoactive Management

Recipients undergo intraoperative circulation phenotyping using pulse contour monitoring and flow-pressure coupling testing. Vasoactive support is assigned according to phenotype: vasopressin infusion for Hyperdynamic physiology, norepinephrine infusion for Mixed Physiology, calcium chloride and/or low-dose dopamine for Poor Contractility, and fluid-guided support for Normal physiology.

Locations (1)

Cedars Sinai Medical Center

Los Angeles, California, United States